As the hair supplements market is projected to reach over $2.86 billion by 2031, there’s a growing shift towards organic and clean-label solutions. Valensa’s CEO, Umasudhan Palaniswamy, has personal experience with the challenges of hair loss. He found that traditional supplements like biotin and pharmaceutical options were not effective or desirable. This led to the development of USPlus® DERM, a breakthrough product utilizing a patent-pending, ultra-high pressure supercritical CO2 process to concentrate key bioactive fatty acids essential for hair follicle health.